A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischaemic stroke

BACKGROUND: Intravenous recombinant tissue plasminogen activator (IV rtPA) is recommended treatment for patients with acute ischaemic stroke, but the cost-effectiveness of IV rtPA within different time windows after the onset of acute ischaemic stroke is not well reviewed. AIMS: To conduct a literat...

Descripción completa

Detalles Bibliográficos
Autores principales: Joo, Heesoo, Wang, Guijing, George, Mary G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516524/
https://www.ncbi.nlm.nih.gov/pubmed/28736623
http://dx.doi.org/10.1136/svn-2016-000063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516524/
https://www.ncbi.nlm.nih.gov/pubmed/28736623
http://dx.doi.org/10.1136/svn-2016-000063

Ejemplares similares